Peripheral PD1-positive CD4 T-lymphocyte count can predict progression-free survival in patients with non-small cell lung cancer receiving immune checkpoint inhibitor
Minehiko Inomata*, Tomonobu Kado, Seisuke Okazawa, Shingo Imanishi, Chihiro Taka, Kenta Kambara, Takahiro Hirai, Hiroaki Tanaka, Kotaro Tokui, Kana Hayashi, Toshiro Miwa, Ryuji Hayashi, Shoko Matsui, Kazuyuki Tobe
*この論文の責任著者
研究成果: ジャーナルへの寄稿 › 学術論文 › 査読
31
被引用数
(Scopus)